Taking the Long View: LA ART for HIV Treatment and Prevention

Download All
Learn with the experts about the latest data and developments on the current and future roles of long-acting ART in HIV treatment and prevention strategies. Listen to podcasts, read ClinicalThought faculty commentaries, download slidesets and patient education sheets, or watch the on-demand multimedia module of this engaging symposium.
Babafemi Taiwo, MBBS
Program Director
person default
Yvonne Gilleece, MB BCh, BAO
Cristina Mussini, MD
Babafemi Taiwo, MBBS
Darrell H. S. Tan, MD, FRCPC, PhD


Here’s my take on incorporating the available evidence to select the right patients for HIV treatment with long-acting injectable cabotegravir plus rilpivirine.

Cristina Mussini, MD Released: July 25, 2022

In this commentary, I share the factors I consider when deciding whether or not to recommend use of the optional 4-week oral lead-in before initiating long-acting cabotegravir plus rilpivirine injections and my thoughts on every-month vs every-2-month dosing.

Darrell H. S. Tan, MD, FRCPC, PhD Released: August 12, 2022

To extend long-acting PrEP to all potential candidates, we must improve our ability to reach individuals wherever they routinely access health services in the community. Here are my thoughts on the barriers we will need to address as we look to the future and the potential for bringing long-acting PrEP even closer to individuals who would benefit.

Babafemi Taiwo, MBBS
Program Director
Released: September 12, 2022

Here is my take on important factors related to the use of long-acting HIV therapies in women, including key findings from several recent studies examining women’s preferences for oral vs long-acting injectable HIV treatment and prevention modalities.

person default Yvonne Gilleece, MB BCh, BAO Released: October 13, 2022

In this commentary, I share my thoughts on why it is important that we strive to overcome the barrier of resistance to change among healthcare professionals when it comes to implementing long-acting HIV treatment and prevention strategies for appropriate individuals who have long awaited these options.

Cristina Mussini, MD Released: November 16, 2022

In this commentary, I share my thoughts on a new option emerging in the realm of long-acting HIV care with potential application to a range of treatment and prevention settings.

Babafemi Taiwo, MBBS Released: December 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings